Ocular hypotensive efficacy and safety of brinzolamide ophthalmic suspension 1% added to travoprost ophthalmic solution 0.004% therapy in patients with openangle glaucoma or ocular hypertension

By Franks Wendy    

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1643-1649

Informa Healthcare

Access to resources Recommend Favorite

Ocular hypotensive efficacy and safety of travoprost 0.004% in inadequately controlled primary open-angle glaucoma or ocular hypertension: short-term, multicenter, prospective study

By Blini Mirella   Rossi Gemma Caterina Maria   Trabucchi Giuseppe   Curatola Maria R.   David Alessandro   Radaelli Rosella   Merlo Giancarlo   Ratiglia Roberto  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 57-63

Informa Healthcare

Access to resources Recommend Favorite

Comparison of morning versus evening dosing and 24-h post-dose efficacy of travoprost compared with latanoprost in patients with open-angle glaucoma**

By Yan David B.   Battista Robert A.   Haidich Anna-Bettina   Konstas Anastasios G. P.  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3023-3027

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertension

By Suzuki Emilio Rintaro   Meirelles Franklin Luciana   da Silva Luciano José Basilio   Figueiredo Carlos R. L.   Agostini Netto Joao   Batista Wagner Duarte  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1799-1805

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and patient tolerability of preservative‐free latanoprost compared with preservative prostaglandin analogs in patients with ocular hypertension or glaucoma

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite